70 results
Page 3 of 4
424B7
i1dsvfrc2q5nhd2xcf7
5 May 22
Prospectus with selling stockholder info
12:00am
6-K
EX-99.1
mzgtf7u78vsmx6
14 Apr 22
Current report (foreign)
4:11pm
F-3ASR
8blpr5rs
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
6-K
EX-99.1
t7v47x5jh n1uv9li
4 Apr 22
European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
rbar 8y7uvu7kse4h
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
elut2
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
3ck9t 462eq4sr
7 Dec 21
Immunocore announces initial Phase 1 data of ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:10pm
6-K
EX-99.3
m45mf
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.2
8p0jzr 0ucgjyfmf6lm
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
xkop2c4mqdvob uosd
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
izsaw4
24 Aug 21
Current report (foreign)
4:33pm
6-K
EX-99.2
pmzcrw 4gn
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.1
w7pmr pxtl6v
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
p6zrd4j56182x
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.2
dvtvvl mp
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.1
pq5fslalw4cxmq86x as
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
aq89pmh7v 98c9
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
20-F
vh3r9mdd4d
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-2.2
81f5mhq7x1
25 Mar 21
Annual report (foreign)
7:01am